Literature DB >> 19616833

Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure.

Pascal Hajj1, Sophie Ferlicot, Walid Massoud, Ayman Awad, Yacine Hammoudi, Bernard Charpentier, Antoine Durrbach, Stéphane Droupy, Gérard Benoît.   

Abstract

OBJECTIVES: To study the prevalence and the characteristics of renal cell carcinoma (RCC) in patients with autosomal dominant polycystic kidney disease (ADPKD) in our series.
METHODS: We reviewed retrospectively all the nephrectomies performed in our department between 1982 and 2003 in patients with ADPKD and chronic renal failure.
RESULTS: Seventy-nine patients (42 males and 37 females) with ADPKD and chronic renal failure underwent 89 nephrectomies; in 10 of 79, both kidneys were removed but not simultaneously. Mean age was 50.4 years (range, 32-69 years). Of 79 patients, 50 had end-stage renal disease (ESRD) and were on hemodialysis or had received a transplant for >1 year. On histologic examination, 11 of 89 kidneys were diagnosed with carcinomas. There was 1 patient with bilateral tumor (tubulopapillary Ca) and 3 kidneys (27.3%) with multifocal tumors. Regarding the histologic type, there were 7 of 12 (58.3%) clear cell carcinomas and the remaining 5 (41.7%) were tubulopapillary carcinomas.
CONCLUSIONS: The prevalence of RCC was higher in patients with ADPKD and ESRD, with >1 year on dialysis or renal transplantation undergoing nephrectomy according the protocol. It would be 2 to 3 times more frequent than RCC in patients with ESRD alone. The clinician should maintain a high alert of suspicion for RCC in such patients.

Entities:  

Mesh:

Year:  2009        PMID: 19616833     DOI: 10.1016/j.urology.2009.02.078

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  33 in total

Review 1.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

2.  Carcinogens induce loss of the primary cilium in human renal proximal tubular epithelial cells independently of effects on the cell cycle.

Authors:  Robert Radford; Craig Slattery; Paul Jennings; Oliver Blacque; Oliver Blaque; Walter Pfaller; Hans Gmuender; Joost Van Delft; Michael P Ryan; Tara McMorrow
Journal:  Am J Physiol Renal Physiol       Date:  2012-01-18

3.  Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease.

Authors:  P Patel; C Horsfield; F Compton; J Taylor; G Koffman; J Olsburgh
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.891

4.  Are acquired cystic kidney disease and autosomal dominant polycystic kidney disease risk factors for renal cell carcinoma in kidney transplant patients?

Authors:  Behzad Einollahi
Journal:  J Nephropathol       Date:  2012-07-01

5.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

6.  An unusual association of autosomal polycystic kidney disease and multiple myeloma.

Authors:  Sanjay Kumar Mandal; Jacky Ganguly; Soumya Sarathi Mondal; Koelina Sil
Journal:  BMJ Case Rep       Date:  2014-01-13

7.  Mutational activation of FGFR3: no involvement in the development of renal cell carcinoma.

Authors:  C G Stoehr; R Stoehr; A Hartmann; F Hofstaedter; K Junker; H Blaszyk; W F Wieland; W Otto; S Denzinger; B Walter
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-28       Impact factor: 4.553

8.  Xp11.2 translocation renal cell carcinoma in the autosomal dominant polycystic kidney disease patient with preserved renal function.

Authors:  Hyuk Huh; Hyung Ah Jo; YongJin Yi; Seung Hyup Kim; Kyung Chul Moon; Curie Ahn; Hayne Cho Park
Journal:  Korean J Intern Med       Date:  2017-10-17       Impact factor: 2.884

Review 9.  Oncological and renal medical importance of kidney-sparing surgery.

Authors:  Paul Russo
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

Review 10.  Surgical cyst decortication in autosomal dominant polycystic kidney disease.

Authors:  Melissa Millar; Youssef S Tanagho; Mohammed Haseebuddin; Ralph V Clayman; Sam B Bhayani; R Sherburne Figenshau
Journal:  J Endourol       Date:  2013-02-05       Impact factor: 2.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.